Your browser doesn't support javascript.
loading
Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.
Abreu, Cecilia; Ortega, Claudia; Olivero-Deibe, Natalia; Carrión, Federico; Gaete-Argel, Aracelly; Valiente-Echeverría, Fernando; Soto-Rifo, Ricardo; Milan Bonotto, Rafaela; Marcello, Alessandro; Pantano, Sergio.
Afiliação
  • Abreu C; Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Ortega C; Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Olivero-Deibe N; Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Carrión F; Institut Pasteur de Montevideo, Montevideo, Uruguay.
  • Gaete-Argel A; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Valiente-Echeverría F; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
  • Soto-Rifo R; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Milan Bonotto R; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
  • Marcello A; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Pantano S; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Front Immunol ; 14: 1226880, 2023.
Article em En | MEDLINE | ID: mdl-37638023
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article